Walsh Helps Client Amgen Win U.S. Patent Battle on Arthritis Drug
Court sides with Amgen in Dispute over Biosimilars NEWARK, NJ, August 12, 2019 – Walsh client Amgen, Inc. prevailed in litigation filed in 2016 challenging two patents for Amgen’s arthritis drug Enbrel® (etanercept). On Friday, August 9, 2019, the Court found in favor of Amgen on...